General Information
Revision date
2015-06-10
Product name
Colistimethate for Injection, USP
CAS No.
8068-28-8
Manufacturer Name
Fresenius Kabi USA, LLC
Icons in SDS
Company Information
company name
Fresenius Kabi USA, LLC
GHS Information
Signal word
WARNING
Section 2
Signal word
WARNING. GHS Class: Specific Target Organ Toxicity - STOT, Single Exposure SE. Category 3.
Hazard statements
May cause respiratory irritation.
Precautionary statements
Avoid breathing dust/fume/gas/mist/vapours/spray. Use only outdoors or in a well-ventilated area. IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. Call a POISON CENTER or doctor/physician if you feel unwell. Store in a well-ventilated place. Keep container tightly closed. Store locked up. Dispose of contents/container in accordance with Local, State, Federal and Provincial regulations. Emergency Overview: This product is intended for therapeutic use only when prescribed by a physician. Potential adverse reactions from prescribed doses and overdoses are described in the package insert.
Principle Routes of Exposure
Inhalation Ingestion Eye contact Skin Absorption. Injection.
Potential health effects
Eye: Contact with eyes may cause irritation. Skin: May cause skin irritation. Inhalation: May cause irritation of respiratory tract. Ingestion: May cause irritation. Signs/Symptoms: Possible adverse reactions include: gastrointestinal upset, tingling of extremities and tongue, slurred speech, dizziness, vertigo, paresthesia, generalized itching, urticaria, rash, and fever. Occupational exposure has not been fully investigated. Aggravation of Pre-Existing Individuals with a history of sensitivity to the drug or any of its components. Conditions:
